SWEDISH ORPHAN BIO

SE0000872095 · SOBI.ST (STO)

0 value funds · 3 CNMV managers

1-year price history

Source: Yahoo Finance

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

Swedish Orphan Biovitrum AB (publ), a biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia. The company operates through three segments: Haematology, Immunology, and Specialty Care.

Healthcare · Drug Manufacturers - Specialty & Generic
https://www.sobi.com

Value funds holding it

Of the value funds we track closely. A different universe and period from "CNMV managers": never added together.

See in Radar Fondos →

CNMV managers

3 → 3 (+0) · net presence change vs. previous period

See context in Radar Gestoras →

Funds (CNMV universe)

3 → 5 (+2) · net presence change vs. previous period

Avg. weight

0.83%

Price

436.40 SEK

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CNMV data · half-year closed 2025-12-31.

Price for SOBI.ST (STO), updated 2026-10-18. Source: Yahoo Finance.

Funds holding this company

CNMV period H2 2025. Weight is the sum of every instrument of the company that fund holds (local share, ADR or another class), not just one.

Fund Manager Weight

GVC GAESCO CROSSOVER, FI GVC GAESCO GESTIÓN, SGIIC, S.A. 1.83% MUTUAFONDO SALUD, FI MUTUACTIVOS, S.A., S.G.I.I.C. 1.81% BBVA EUROPA DESARROLLO, FI BBVA ASSET MANAGEMENT, S.A., SGIIC 0.43% BINDEX EUROPA INDICE, FI BBVA ASSET MANAGEMENT, S.A., SGIIC 0.05% BINDEX EUROPA CTB INDICE, FI BBVA ASSET MANAGEMENT, S.A., SGIIC 0.02%

Company-level moves

Compares H1 2025 with H2 2025, summing every instrument of the company each fund holds. A fund switching instrument within the same company doesn't show up here as an entry or exit — for that instrument-by-instrument detail, see the Instruments section.

New positions: 2 Exits: 0 Increasing exposure: 0 Reducing exposure: 1

+ BINDEX EUROPA CTB INDICE, FI

Enters the position at 0.02% weight.

+ BBVA EUROPA DESARROLLO, FI

Enters the position at 0.43% weight.

Objective ratios

FCF yield

2.2%

Net debt / EBITDA

1.33x

P/E

—

52-week range

262.80 – 487.00 SEK

Data as-is, not an interpretation: it does not say whether the price is cheap or expensive, and it is not a buy or sell recommendation.

Updated 2026-09-06. Source: Yahoo Finance.

Disclaimer

This is not financial advice. Weights come from the periodic reports each manager files with the CNMV and lag the real close of the period. Price, description and ratios, when available, come from Yahoo Finance and may not exactly match this ISIN if the company has multiple share classes.